Jianbin Bi
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC (NCT06971211) | Jianbin Bi | 2024-11-27 |
| Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer (NCT06134271) | Jianbin Bi | 2023-11-15 |
Track Jianbin Bi automatically
Every clearance here is in the API, with alerts when new ones post.